{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 58003
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10004132",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "2",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-JNJFOC-20140300548",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "JANSSEN",
        "duplicatenumb": "US-JNJFOC-20140300548"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Platelet count decreased",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Pyrexia",
            "reactionoutcome": "2"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Prostatic specific antigen increased",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Bone pain",
            "reactionoutcome": "2"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ZYTIGA",
            "drugauthorizationnumb": "202379",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugindication": "PROSTATE CANCER",
            "actiondrug": "1",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA202379"
              ],
              "brand_name": [
                "ZYTIGA"
              ],
              "generic_name": [
                "ABIRATERONE ACETATE"
              ],
              "manufacturer_name": [
                "Janssen Biotech, Inc."
              ],
              "product_ndc": [
                "57894-150",
                "57894-195"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ABIRATERONE ACETATE"
              ],
              "rxcui": [
                "1100075",
                "1100079",
                "1918042",
                "1918044"
              ],
              "spl_id": [
                "316974bf-2b6d-9d66-e063-6294a90a33a9"
              ],
              "spl_set_id": [
                "4e338e89-3cf2-48eb-b6e2-a06c608c6513"
              ],
              "package_ndc": [
                "57894-150-12",
                "57894-150-25",
                "57894-195-06",
                "57894-195-15"
              ],
              "unii": [
                "EM5OCB9YJ6"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "XTANDI",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "065",
            "drugindication": "PROSTATE CANCER",
            "actiondrug": "1",
            "openfda": {
              "application_number": [
                "NDA203415",
                "NDA213674"
              ],
              "brand_name": [
                "XTANDI"
              ],
              "generic_name": [
                "ENZALUTAMIDE"
              ],
              "manufacturer_name": [
                "Astellas Pharma US, Inc."
              ],
              "product_ndc": [
                "0469-0125",
                "0469-0625",
                "0469-0725",
                "0469-1125",
                "0469-1725"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ENZALUTAMIDE"
              ],
              "rxcui": [
                "1307303",
                "1307309",
                "2390644",
                "2390646",
                "2390648",
                "2390650"
              ],
              "spl_id": [
                "cfc2fbc2-2657-407f-b0f0-bd41fb98d89e"
              ],
              "spl_set_id": [
                "b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf"
              ],
              "package_ndc": [
                "0469-0125-99",
                "0469-0625-99",
                "0469-0725-60",
                "0469-1125-56",
                "0469-1725-56"
              ],
              "nui": [
                "N0000175560",
                "N0000000243",
                "N0000185506",
                "N0000185507",
                "N0000185607"
              ],
              "pharm_class_epc": [
                "Androgen Receptor Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Androgen Receptor Antagonists [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]"
              ],
              "unii": [
                "93T0T9GKNU"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "XTANDI",
            "drugdosageform": "Unspecified",
            "drugadministrationroute": "065",
            "drugindication": "PROSTATE CANCER",
            "actiondrug": "1",
            "openfda": {
              "application_number": [
                "NDA203415",
                "NDA213674"
              ],
              "brand_name": [
                "XTANDI"
              ],
              "generic_name": [
                "ENZALUTAMIDE"
              ],
              "manufacturer_name": [
                "Astellas Pharma US, Inc."
              ],
              "product_ndc": [
                "0469-0125",
                "0469-0625",
                "0469-0725",
                "0469-1125",
                "0469-1725"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ENZALUTAMIDE"
              ],
              "rxcui": [
                "1307303",
                "1307309",
                "2390644",
                "2390646",
                "2390648",
                "2390650"
              ],
              "spl_id": [
                "cfc2fbc2-2657-407f-b0f0-bd41fb98d89e"
              ],
              "spl_set_id": [
                "b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf"
              ],
              "package_ndc": [
                "0469-0125-99",
                "0469-0625-99",
                "0469-0725-60",
                "0469-1125-56",
                "0469-1725-56"
              ],
              "nui": [
                "N0000175560",
                "N0000000243",
                "N0000185506",
                "N0000185507",
                "N0000185607"
              ],
              "pharm_class_epc": [
                "Androgen Receptor Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Androgen Receptor Antagonists [MoA]",
                "Cytochrome P450 3A4 Inducers [MoA]",
                "Cytochrome P450 2C9 Inducers [MoA]",
                "Cytochrome P450 2C19 Inducers [MoA]"
              ],
              "unii": [
                "93T0T9GKNU"
              ]
            }
          }
        ]
      }
    }
  ]
}